CNBX

Cannabics Pharmaceuticals Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 6/12/2017
Contact Info
  • #3 Bethesda Metro Center
  • Suite 700
  • Bethesda, MD 20814

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report May 31, 2017 10-Q
CIK 0001343009
Fiscal Year End 8/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 2 a/o Apr 30, 2016
Company Officers/Contacts
Itamar Borochov CEO
Uri Ben-Or CFO
Eyal Ballan CTO
Company Directors
Eyal Ballan
Itamar Borochov
Service Providers
Accounting/Auditing Firm
Weinberg & Baer LLC
115 Sudbrook Lane
Baltimore, MD, 21208
United States
 
Securities Counsel
Law Offices of David E. Price
# 3 Bethesda Metro Center
Suite 700
Bethesda, MD, 20814
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=American Mining Corporation until 6-2014
  • Formerly=Thrust Energy Corp. until 5-2011
CNBX Security Details
Share Structure
Market Value1 $97,225,345 a/o Oct 17, 2017
Authorized Shares 900,000,000 a/o Oct 16, 2017
Outstanding Shares 119,564,840 a/o Oct 16, 2017
-Restricted 89,516,095 a/o Oct 16, 2017
-Unrestricted 30,048,745 a/o Oct 16, 2017
Held at DTC 25,996,023 a/o Oct 16, 2017
Float 21,943,046 a/o Jun 01, 2017
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
ClearTrust, LLC
Shareholders
Shareholders of Record 69 a/o Jun 01, 2017
Short Selling Data
Short Interest 244,362 (-5.25%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security